Novartis

4 Novartis Claims Dropped In Retisert Sales Spat

pharmiweb.co.uk
14-Nov-2008
        

Law360, New York (November 14, 2008) -- A federal judge has slashed four claims from a sales contract dispute brought by Novartis Pharmaceuticals Corp. against Bausch & Lomb Inc. including a misappropriation of confidential...

add comment
                   

Millions Mark World Diabetes Day

medicalnewstoday.com
14-Nov-2008 125 related
        

November 14 is the most important day of the year for the over 250 million people with diabetes worldwide. World Diabetes Day draws attention to the global diabetes epidemic and the need for action to improve care, prevent the...

add comment
                   

Modern cancer drugs more likely to get to market

reuters.com
14-Nov-2008 97 related
        

LONDON (Reuters) - Nearly one in five cancer drugs entering development now reach the market, a remarkably good success rate given the high level of failures in other disease areas, British researchers said on Friday .

add comment
                   
newstarget.com: drug companies newstarget.com

Drug Companies Pay "Opinion Leaders" to Push Pills During Influential Meetings, Seminars

newstarget.com
14-Nov-2008 2 related
        

An article published in the British Medical Journal, also known as BMJ, has revealed the extent to which pharmaceutical companies go to turn influential senior doctors into undercover salespeople for their drugs."Key opinion...

add comment
                   
pharmalot.com: stem-cells pharmalot.com

Pfizer Ready for Stem Cell Deals (at The Wall Street Journal Online)

yahoo.com
14-Nov-2008 32 related
        

More news today on the Pfizer stem cell initiative we wrote about in September. It sounds like the effort, to be known as Pfizer Regenerative Medicine, will include a fair bit of deal making — always interesting when you’re...

add comment
                   

Modern cancer drugs more likely to get to market (Reuters)

health.yahoo.com
14-Nov-2008 7 related
        

Reuters - Nearly one in five cancer drugs entering development now reach the market, a remarkably good success rate given the high level of failures in other disease areas, British researchers said on Friday .

add comment

Stock Picker: Buy Black Ink (at CNBC)

yahoo.com
14-Nov-2008 5 related
        

STOCKS, STOCK MARKET, CNBC, CNBC.COM, STOCK BLOG, CNBC STOCK BLOG, INVESTMENT, PORTFOLIO When it comes to where investors should put their money now, Delphi Management's Scott Black is very specific. The economic crisis is far...

add comment
                   

Stock Picks: Big Names, Strong Balance Sheets Are Cheap (at CNBC)

yahoo.com
14-Nov-2008 1 related
        

PHARMACEUTICALS, BALANCE SHEETS, TECHNOLOGY, ORACLE, GENERAL ELECTRIC, GENERAL DYNAMICS, GOLDMAN SACHS, PEPSI, PHARMACEUTICALS HOLDINGS To give investors an edge in this volatile market environment, CNBC asked the pros for...

add comment
                   

The Obama Portfolio (at Kiplinger.com)

yahoo.com
14-Nov-2008
        

These five companies could get a bump when the president-elect takes office. Whatever the market's initial response, investors will watch the new president closely for clues that could determine which industries are most likely...

add comment
genengnews.com: Genetic Engineering genengnews.com

Unigene Laboratories, Inc. Joins Scrip World´s Biotechnology Top Fifty

euroinvestor.co.uk
14-Nov-2008 4 related
        

Unigene Laboratories, Inc. (OTCBB: UGNE, http:// www.unigene.com), a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs, has been included in the Scrip W.. - Read more

add comment